We consider that CD8+ CTLs are necessary for tumor regression and CD4+ helper T cell responses play a pivotal role in activating these CD8+ CTLs in this vaccine models using miPSDCs expressing CEA3,31. The gene discussed is CD8A; the disease is neoplasm.